CareDx, Inc. is a company in the U.S. stock market and it is a holding in 58 U.S.-traded ETFs. CDNA has around 8.5M shares in the U.S. ETF market. The largest ETF holder of CDNA is the ARK Genomic Revolution ETF (ARKG), with approximately 3.70M shares. Investors may also find of interest that the ETF with the largest allocation to CDNA stock is Global X Genomics & Biotechnology ETF (GNOM), with a portfolio weight of 3.95%. On average, U.S. ETFs allocate 0.34% of CDNA to their portfolios.
Additionally, CDNA is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with CDNA as a holding is the ProShares UltraPro Russell2000 (URTY), with a return of 167.77%.